Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | UCHL1 | P09936 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | HRH2 | P25021 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5479849 | 0.86 | NR1H2 (0.44) | HSD17B10LMNASMN1; SMN2HPGDMEN1 | |
| SCHEMBL239130 | 0.85 | HSD17B10 (0.59) | HSD17B10NPC1UCHL1LMNANPSR1 | |
| SCHEMBL2225858 | 0.85 | HSD17B10 (0.59) | HSD17B10NPC1UCHL1LMNANPSR1 | |
| SCHEMBL240483 | 0.85 | HSD17B10 (0.59) | HSD17B10NPC1UCHL1LMNANPSR1 | |
| SCHEMBL1478184 | 0.81 | HSD17B10 (0.55) | HSD17B10NPC1UCHL1LMNANPSR1 | |
| SCHEMBL1478166 | 0.81 | HSD17B10 (0.55) | HSD17B10NPC1UCHL1LMNANPSR1 | |
| SCHEMBL82116 | 0.81 | HSD17B10 (0.55) | HSD17B10NPC1UCHL1LMNANPSR1 | |
| SCHEMBL8476456 | 0.81 | HSD17B10 (0.48) | HSD17B10MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL23458143 | 0.78 | NR1H2 (0.42) | HSD17B10NPC1LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL21714024 | 0.78 | HSD17B10 (0.45) | HSD17B10NPC1LMNASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030225102-A1 | Novel compounds and therapeutic uses thereof | TORRENT PHARMACEUTICALS LTD. | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225102-A1 | Novel compounds and therapeutic uses thereof | GPR119, SLC5A1, SLC2A4 | HSD17B10 1596/4885NPC1 531/4885UCHL1 2652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.